Mental Health Clinical Trials Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Mental Health Clinical Trials Market Size Analysis and Top Companies

The mental health clinical trials market size is estimated to hit around USD 6.52 billion by 2033 from USD 3.17 billion in 2024 with a CAGR of 8.32%. The major players operating in the mental health clinical trials market are ICON Plc, Eli Lilly Company, Caidya, Syneous Health, Novo Nordisk, Pharmaceutical Product Development, LLC, Parexel International Corporation, Corcept, Labcorp Drug Development, IQVIA, and Others.

Market Report Coverage 

Mental Health Clinical Trials Market Companies

• ICON Plc
• Eli Lilly Company
• Caidya
• Syneous Health
• Novo Nordisk
• Pharmaceutical Product Development, LLC
• Parexel International Corporation
• Corcept
• Labcorp Drug Development
• IQVIA

Recent Developments

• In April 2024, the international pharmaceutical business Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) announced the opening of My Mental Health Journey, a longitudinal registry project with the goal of advancing mental health and depression research.
• In February 2024, the Bazouki Group declared the beginning of a new collaboration on a clinical study of a therapeutic ketogenic diet for bipolar illness with McLean Hospital in Belmont, Massachusetts. Investigating nutritional ketosis as a unique therapeutic approach and a crucial tool for comprehending the underlying processes of bipolar disease.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344